Basic Information
LncRNA/CircRNA Name | MEG3 |
Synonyms | GTL2, FP504, or LINC00023 |
Region | GRCh38_14:100779410-100861031 |
Ensemble | ENSG00000214548 |
Refseq | NR_002766 |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | apoptosis | Drug | ||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | breast cancer |
ICD-0-3 | C50 |
Methods | qPCR, Western blot, in vitro knockdown, etc. |
Sample | Human breast cancer cell line MDA-MB-231 and breast cell line MCF7 |
Expression Pattern | down-regulated |
Function Description | Ectopic overexpression of MEG3 using a lentiviral vector Lv MEG3 significantly inhibited breast cancer cell growth in vitro and a cancer xenograft growth in vivo. MEG3 overexpression led to marked increase of apoptosis in breast cancer cells as determined using flow cytometry and fragmented DNA labeling. Moreover, ectopic expression of MEG3 increased the expression of endoplasmic reticulum (ER) stress related proteins required for unfolded protein response, including glucose regulated protein 78 (GRP78), inositol requiring enzyme 1 (IRE1), protein kinase RNA (PKR) like ER kinase (PERK), and activated transcription factor 6 (ATF6), as well as proapoptotic proteins CCAAT/enhancer binding protein homologous protein (CHOP) and caspase 3. Finally, MEG3 overexpression markedly increased nuclear factor ?B (NF ?B) expression, NF ?B translocation to the nucleus, and p53 expression, whereas pharmacological inhibition of NF ?B completely abolished MEG3 induced activation of p53. |
Pubmed ID | 30556250 |
Year | 2018 |
Title | Long Noncoding RNA MEG3 Inhibits Breast Cancer Growth via Upregulating Endoplasmic Reticulum Stress and Activating NF-?B and p53 |
External Links
Links for MEG3 | GenBank HGNC NONCODE |
Links for breast cancer | OMIM COSMIC |